Gestrinone

Subscribe to Selected New Research on Gestrinone

85 relevant articles (14 outcomes, 21 trials/studies) found for this Bio-Agent

Description: A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can also be used in intravaginal devices.

Also Known As:

Aventis Brand of Gestrinone; Dimetriose; Florizel Brand of Gestrinone; Hoechst Brand of Gestrinone; Nemestran; R-2323; R2323; R 2323; 18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Experts

1.	Liu, Gui-Ming: 1 article (05/2007)
2.	Wu, Jian-Hui: 1 article (05/2007)
3.	Qiu, Xiao-Yan: 1 article (05/2007)
4.	Jiang, Xiu-Rong: 1 article (05/2007)
5.	He, Gui-Lin: 1 article (05/2007)
6.	Sun, Zu-Yue: 1 article (05/2007)
7.	Zhu, Yan: 1 article (05/2007)
8.	Cao, Lin: 1 article (05/2007)
9.	Wang, Lei: 1 article (05/2007)
10.	Ma, Wen-guang: 1 article (09/2006)

Related Diseases

1.	Endometriosis (Adenomyosis) 01/31/1987 - "There was a significant difference in improvement of the disease in the gestrinone group compared with placebo (p = 0.004), confirming that gestrinone is an effective treatment of endometriosis" 08/01/1995 - "The results indicate that gestrinone is effective in the treatment of pelvic endometriosis" 08/01/1996 - "CONCLUSIONS: Gestrinone 2.5 mg given twice a week for six months provides an effective and safe treatment for those women suffering from endometriosis." 09/01/2006 - "Comparative study on the efficacy of Yiweining and Gestrinone for post-operational treatment of stage III endometriosis." 01/01/1997 - "OBJECTIVE: The clinical and histological efficacy of gestrinone in the treatment of endometriosis was evaluated" Order ALL the reference details at left...
2.	Infertility (Sterility) 05/02/1987 - "The relation between asymptomatic endometriosis and infertility was investigated in a randomised double blind placebo controlled trial of the impact of treating the endometriosis with gestrinone" 01/01/1999 - "The results suggest that gestrinone may be considered an option for the treatment of endometriosis related infertility." 10/01/1992 - "Gestrinone in the therapy of sterility due to endometriosis]" 05/01/1989 - "The results of this study suggest that gestrinone is as effective as danazol in the treatment of infertility associated with endometriosis and is better tolerated." 11/01/1987 - "A clinicopathologic study of a short-term medical treatment of endometriosis with danazol or gestrinone was performed in 50 patients with endometriosis and infertility" Order ALL the reference details at left...
3.	Pain (Aches) 01/25/1992 - "The gestrinone group had significantly greater reductions than the placebo group in breast pain score at months 1, 2, and 3 of treatment (mean reduction 59.5 [SD 22.6] to 11.7 [17.0] vs 58.2 [17.6] to 36.7 [23.0] at month 3; p less than 0.0001)" 01/25/1992 - "Multicentre study of gestrinone in cyclical breast pain." 12/01/1996 - "A tendency to prolonged pain reduction was observed after gestrinone compared with LA treatment" 12/01/1996 - "Moderate or severe pain symptoms recurrence on both pain scales was observed in 2 of 17 (11.8%) patients given gestrinone compared with 9 of 17 (52.9%) of those given LA (odds ratio, 0.12; 95% confidence interval, 0.02 to 0.69)" 02/29/1992 - "Gestrinone in cyclical breast pain." Order ALL the reference details at left...
4.	Pelvic Pain 12/01/1996 - "OBJECTIVES: To evaluate the efficacy of gestrinone versus leuprolide acetate (LA) in improving pelvic pain in women with endometriosis and to compare their effects on bone mineral density and serum lipid profile" 12/01/1996 - "Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study" Order ALL the reference details at left...
5.	Dysmenorrhea (Menstrual Pain) 04/01/1988 - "The results were as follows; 1) Dysmenorrhea was relieved in 60.0% of the Gestrinone-treated group and 45.5% of the Danazol group" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Danazol (Azol)
2.	Buserelin (Suprefact)
3.	Gonadotropin-Releasing Hormone (GnRH)
4.	Medroxyprogesterone 17-Acetate (Depo-Provera)
5.	Leuprolide (Lupron)
6.	Steroid Receptors (Steroid Receptor)
7.	Gestrinone
8.	Testosterone (Sustanon)
9.	Lipoproteins (Lipoprotein)
10.	Dopamine Agonists (Dopamine Agonist)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Ovulation Inhibition
3.	Laparotomy
4.	Intrauterine Devices (Intrauterine Device)
5.	Contraception (Birth Control)

Best Treatments:
Research Summary Report
on Endometriosis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 365 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>